美国 · SEC FORM 4
BIO-RAD LABORATORIES, INC.
BIO BIO.B · NYSE · CIK 0000012208 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
51 同一窗口内观察到的 Form 4 交易行
1 sales · 50 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 7 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
FINRA 报告中没有该股票代码的空头余额。
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
本地 Form 4 历史中没有合资格的代码 P 股票买入。
Form 4 申报证据
56 transaction lines in the latest 365-day window; 591 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-06 | SCHWARTZ NORMAN D | 期权行权/转换 (M) | Bio-Rad A Common Stock | 3,455 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-06 | SCHWARTZ NORMAN D | 代扣税 (F) | Bio-Rad A Common Stock | 1,854 | USD 386.11 | USD 715,848 | SEC 申报 ↗ |
| 2026-09-06 | Lakkaraju Roop Kalyan | 期权行权/转换 (M) | Bio-Rad A Common Stock | 1,536 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-06 | SCHWARTZ NORMAN D | 期权行权/转换 (M) | Bio-Rad A Common Stock | 3,455 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-06 | SCHWARTZ NORMAN D | 代扣税 (F) | Bio-Rad A Common Stock | 1,854 | USD 386.11 | USD 715,848 | SEC 申报 ↗ |
| 2026-09-06 | Lakkaraju Roop Kalyan | 期权行权/转换 (M) | Bio-Rad A Common Stock | 1,536 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-06 | Lakkaraju Roop Kalyan | 代扣税 (F) | Bio-Rad A Common Stock | 782 | USD 386.11 | USD 301,938 | SEC 申报 ↗ |
| 2026-09-06 | EVRAN SEDAT | 期权行权/转换 (M) | Bio-Rad A Common Stock | 864 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-06 | EVRAN SEDAT | 代扣税 (F) | Bio-Rad A Common Stock | 277 | USD 386.11 | USD 106,952 | SEC 申报 ↗ |
| 2026-09-06 | ENLOE COURTNEY C | 期权行权/转换 (M) | Bio-Rad A Common Stock | 768 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-06 | ENLOE COURTNEY C | 代扣税 (F) | Bio-Rad A Common Stock | 305 | USD 386.11 | USD 117,764 | SEC 申报 ↗ |
| 2026-09-06 | ENGELHARDT EVA ANETTE | 期权行权/转换 (M) | Bio-Rad A Common Stock | 1,152 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-06 | ENGELHARDT EVA ANETTE | 代扣税 (F) | Bio-Rad A Common Stock | 485 | USD 386.11 | USD 187,263 | SEC 申报 ↗ |
| 2026-09-06 | BARRY JAMES | 期权行权/转换 (M) | Bio-Rad A Common Stock | 1,056 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-06 | BARRY JAMES | 代扣税 (F) | Bio-Rad A Common Stock | 470 | USD 386.11 | USD 181,472 | SEC 申报 ↗ |
| 2026-09-06 | Allison Schwartz | 期权行权/转换 (M) | Bio-Rad A Common Stock | 92 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-06 | Allison Schwartz | 代扣税 (F) | Bio-Rad A Common Stock | 34 | USD 386.11 | USD 13,128 | SEC 申报 ↗ |
| 2026-09-05 | SCHWARTZ NORMAN D | 期权行权/转换 (M) | Bio-Rad A Common Stock | 4,109 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-05 | SCHWARTZ NORMAN D | 代扣税 (F) | Bio-Rad A Common Stock | 2,876 | USD 386.11 | USD 1,110,452 | SEC 申报 ↗ |
| 2026-09-05 | Mehta Rajat | 期权行权/转换 (M) | Bio-Rad A Common Stock | 1,826 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-05 | Mehta Rajat | 代扣税 (F) | Bio-Rad A Common Stock | 737 | USD 386.11 | USD 284,563 | SEC 申报 ↗ |
| 2026-09-05 | Lakkaraju Roop Kalyan | 期权行权/转换 (M) | Bio-Rad A Common Stock | 1,370 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-05 | Lakkaraju Roop Kalyan | 代扣税 (F) | Bio-Rad A Common Stock | 559 | USD 386.11 | USD 215,835 | SEC 申报 ↗ |
| 2026-09-05 | EVRAN SEDAT | 期权行权/转换 (M) | Bio-Rad A Common Stock | 1,027 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-05 | EVRAN SEDAT | 代扣税 (F) | Bio-Rad A Common Stock | 329 | USD 386.11 | USD 127,030 | SEC 申报 ↗ |
| 2026-09-05 | ENLOE COURTNEY C | 期权行权/转换 (M) | Bio-Rad A Common Stock | 685 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-05 | ENLOE COURTNEY C | 代扣税 (F) | Bio-Rad A Common Stock | 246 | USD 386.11 | USD 94,983 | SEC 申报 ↗ |
| 2026-09-05 | ENGELHARDT EVA ANETTE | 期权行权/转换 (M) | Bio-Rad A Common Stock | 1,027 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-05 | ENGELHARDT EVA ANETTE | 代扣税 (F) | Bio-Rad A Common Stock | 369 | USD 386.11 | USD 142,475 | SEC 申报 ↗ |
| 2026-09-05 | DiVincenzo Jonathan P. | 期权行权/转换 (M) | Bio-Rad A Common Stock | 1,712 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-05 | DiVincenzo Jonathan P. | 代扣税 (F) | Bio-Rad A Common Stock | 668 | USD 386.11 | USD 257,921 | SEC 申报 ↗ |
| 2026-09-05 | BARRY JAMES | 期权行权/转换 (M) | Bio-Rad A Common Stock | 1,027 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-05 | BARRY JAMES | 代扣税 (F) | Bio-Rad A Common Stock | 369 | USD 386.11 | USD 142,475 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | BIO BIO.B |
| CIK | 0000012208 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3826 Laboratory Analytical Instruments |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 591 transaction lines from 2020-04-08 to 2026-09-06 0 P purchase lines · 56 S sale lines · 535 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.